Innovative Medical Management Co.,Ltd. (SHE:002173)
China flag China · Delayed Price · Currency is CNY
19.02
-0.52 (-2.66%)
Aug 3, 2026, 3:05 PM CST

SHE:002173 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Net Income
-46.07-34.85-93.95-34.29-73.42-103.46
Depreciation & Amortization
92.192.1101.94106.66110.26115.76
Other Amortization
10.910.96.646.369.499.97
Loss (Gain) From Sale of Assets
-0.02-0.021.42-1.061.16-0.06
Asset Writedown & Restructuring Costs
3.053.053.395.2611.61.24
Loss (Gain) From Sale of Investments
-36.93-36.93-1.981.84-2.66-15.84
Provision & Write-off of Bad Debts
-3.98-3.982.423.35-2.333.52
Other Operating Activities
5.432.464.33.633.75-3.19
Change in Accounts Receivable
3939-27.79-49.0735.9911.69
Change in Inventory
5.935.93-0.476.82-6.7-8.01
Change in Accounts Payable
-10.81-10.81-1.542.39-18.0619.15
Change in Other Net Operating Assets
2.542.546.54-37.7-91.8316.5
Operating Cash Flow
67.6975.93-7.3411.03-24.4543.37
Operating Cash Flow Growth
349.44%-----67.06%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Capital Expenditures
-56.27-84.52-46.95-96.24-123.18-110.72
Sale of Property, Plant & Equipment
0.10.10.080.340.290.15
Cash Acquisitions
-1.07-1.07---0.6-1.68
Divestitures
--3.88-0.7737.3
Investment in Securities
27.1187.94-87.32-3205655
Other Investing Activities
--0.090.5517.7317.57
Investing Cash Flow
-30.132.45-129.92-415.34460.01-52.39

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Short-Term Debt Issued
----233
Long-Term Debt Issued
-23.0153.9131.16--
Total Debt Issued
28.0123.0153.9131.16233
Short-Term Debt Repaid
-----12-33
Long-Term Debt Repaid
--29.51-45.57-34.67-13.18-30.66
Total Debt Repaid
-34.51-29.51-45.57-34.67-25.18-63.66
Net Debt Issued (Repaid)
-6.5-6.58.34-3.51-2.18-60.66
Repurchase of Common Stock
----0--48.4
Common Dividends Paid
-2.59-2.59-2.59-1.46-0.79-2.35
Other Financing Activities
1.47-----
Financing Cash Flow
-7.62-9.095.75-4.98-2.97-111.41

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Net Cash Flow
29.9469.29-131.52-409.29432.59-120.43

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Free Cash Flow
11.42-8.59-54.3-85.21-147.62-67.35
Free Cash Flow Growth
------
Free Cash Flow Margin
1.51%-1.10%-6.65%-10.58%-20.80%-9.47%
Free Cash Flow Per Share
0.03-0.02-0.12-0.20-0.33-0.15
Levered Free Cash Flow
--14.56-13.73-55.2-65.25-44.18
Unlevered Free Cash Flow
--12.17-11.18-52.92-63.15-40.39

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash Income Tax Paid
14.3215.1413.0812.197.7716.35
Change in Working Capital
43.243.2-31.51-80.72-82.2935.42